Pyridine appended 2-hydrazinylthiazole derivatives: design, synthesis, <i>in vitro</i> and <i>in silico</i> antimycobacterial studies-Reference-Cited by-同舟云学术

Pyridine appended 2-hydrazinylthiazole derivatives: design, synthesis, in vitro and in silico antimycobacterial studies

Published:2022 Issue:29 Volume:12 Page:18333-18346
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Matsa Ramkishore¹,Makam Parameshwar²³,Sethi Guneswar⁴,Thottasseri Ahammed Ameen¹^ORCID,Kizhakkandiyil Aswani Raj¹,Ramadas Krishna⁴,Mariappan Vignesh⁵,Pillai Agieshkumar Balakrishna⁵,Kannan Tharanikkarasu¹^ORCID

Affiliation:

1. Department of Chemistry, Pondicherry University, Kalapet, Puducherry 605 014, India

2. Dr Param Laboratories, Plot No. 478, BN. Reddy Nagar, Cherlapally, Hyderabad, Telangana 500 051, India

3. Division of Research and Innovation, Department of Chemistry, Uttaranchal University, Arcadia Grant, P.O. Chandanwari, Premnagar, Dehradun, Uttarakhand, 248007, India

4. Centre for Bioinformatics, Pondicherry University, Puducherry 605 014, India

5. Central Inter-Disciplinary Research Facility (CIDRF), Sri Balaji Vidyapeeth (Deemed to be University), Puducherry 607 402, India

Abstract

Thirty novel pyridine-appended 2-hydrazinylthiazole derivatives have been synthesized and tested for their antimycobacterial activity against Mictrobactrium tuberculosis, H37Rv strain.

Funder

University Grants Commission

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/RA/D2RA02163C

Reference44 articles.

1. World Health Organization , Global Tuberculosis Report 2021 , 2021

2. Treatment of Tuberculosis

3. Current Status and Research Strategies in Tuberculosis Drug Development